The UK Office for National Statistics (ONS) publish a regular infection survey that reports data on positive RT-PCR test results for SARS-COV-2 virus. This survey reports that a large proportion of positive test results are based on the detection of a single gene rather than on two or more genes as required in the manufacturer instructions for use, and by the WHO in their emergency use assessment. The proportion of positives called on single genes increased from mid-November to mid-December 2020, suggesting a shift in testing policy coincident with the reported significant increase in transmission of the new variant B1.1.7, and again starting January 2021. Without diagnostic validation of the single gene call, for both the original and the B1.1.7 variant it can only be assumed that, in the absence of confirmatory testing, many of the reported positive results may in fact be inconclusive, negative or from people who suffered past infection for SARS-COV-2.
翻译:英国国家统计局(ONS)公布定期感染调查,其中报告关于SARS-COV-2病毒的RT-PCR检测结果正数数据,该调查报告说,大部分正数检测结果都基于检测单一基因,而不是制造商使用指令中所要求的两种或两种以上基因,以及世卫组织在紧急使用评估中所要求的两种或两种以上基因,使用单一基因的阳性比例从11月中旬到2020年12月中旬上升,表明检测政策的变化与所报告的新变异B1.1.7的传播显著增加相吻合,并再次从2021年1月开始。如果不对原变异和B1.1.7变异的单一基因呼声进行诊断性验证,只能假定,在没有确认性测试的情况下,所报告的许多阳性结果事实上可能是无结果、负结果,也可能是过去感染SARS-COV-2的人的阳性结果。